首页> 外文OA文献 >Phase II, Multicenter, Single-Arm, Feasibility Study of Eribulin Combined With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive, Early-Stage Breast Cancer

【2h】

Phase II, Multicenter, Single-Arm, Feasibility Study of Eribulin Combined With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive, Early-Stage Breast Cancer

机译：依瑞布林联合卡培他滨联合多期单臂治疗II期在雌激素受体阳性早期乳腺癌中辅助治疗的可行性研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Smith John W.; Vukelja Svetislava; Hoffman Anthony D.; Jones Vicky E.; McIntyre Kristi; Berrak Erhan; Song James X.; OShaughnessy Joyce;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 来自一项艾日布林联合吉西他滨对比紫杉醇联合吉西他滨作为HER2阴性转移性乳腺癌的一线化疗的II期、多中心、随机试验的包含神经病变相关量表的生活质量结果:韩国癌症研究组试验(KCSG BR13-11) [J] . Ji-Yeon Kim, Young-Hyuck Im, Tae-Yong Kim, 癌症（英文版） . 2019,第008期
2. Phase II, Multicenter, Single-Arm, Feasibility Study of Eribulin Combined With Capecitabine for Adjuvant Treatment in Estrogen Receptor Positive, Early-Stage Breast Cancer [J] . Smith John W. II, Vukelja Svetislava, Hoffman Anthony D., Clinical breast cancer . 2016,第1期

机译：依瑞布林联合卡培他滨联合多期单臂治疗II期在雌激素受体阳性，早期乳腺癌中辅助治疗的可行性研究
3. Clinical effects of prior trastuzumab on combination eribulin mesylate plus trastuzumab as first-line treatment for human epidermal growth factor receptor 2 positive locally recurrent or metastatic breast cancer: results from a Phase II, single-arm, multicenter study [J] . Shannon Puhalla, Sharon Wilks, Adam M Brufsky, Breast Cancer: Targets and Therapy . 2016,第1期

机译：先前的曲妥珠单抗联合甲磺酸艾瑞布林加曲妥珠单抗作为人表皮生长因子受体2阳性局部复发或转移性乳腺癌的一线治疗的临床效果：II期，单臂，多中心研究的结果
4. The West German Study Group Breast Cancer Intrinsic Subtype study: a prospective multicenter decision impact study utilizing the Prosigna assay for adjuvant treatment decision-making in estrogen-receptor-positive, HER2-negative early-stage breast cancer [J] . Wuerstlein R., Sotlar K., Gluz O., Current medical research and opinion . 2016,第7期

机译：西德研究小组的乳腺癌固有亚型研究：一项前瞻性多中心决策影响研究，利用Prosigna分析方法对雌激素受体阳性，HER2阴性早期乳腺癌的辅助治疗做出决策
5. Estrogen Receptor-Positive Breast Cancer: Traditional Prognostics, Molecular Pathology: A New Breast Cancer Taxonomy and 21st Century Personalized Prognostic and Predictive Assays [C] . Frederick L. Baehner International Symposium on Cancer Metastasis and the Lymphovascular system: Basis for Rational Therapy . 2009

机译：雌激素受体阳性乳腺癌：传统预测，分子病理：新的乳腺癌分类和21世纪个性化预测和预测测定
6. Prospective Phase II Multicenter Registry of Ablation after Breast Lumpectomy Added to Extend (ABLATE) Intraoperative Margins in the Treatment of Breast Cancer [D] . Klimberg, V. Suzanne. 2017

机译：乳房肿块切除术后消融的前瞻性II期多中心消融术增加了扩大（ABLATE）术中切缘在治疗乳腺癌中的作用
7. Clinical effects of prior trastuzumab on combination eribulin mesylate plus trastuzumab as first-line treatment for human epidermal growth factor receptor 2 positive locally recurrent or metastatic breast cancer: results from a Phase II single-arm multicenter study [O] . Shannon Puhalla, Sharon Wilks, Adam M Brufsky, 2016

机译：先前的曲妥珠单抗联合甲磺酸埃里布林联合曲妥珠单抗作为人表皮生长因子受体2阳性局部复发或转移性乳腺癌的一线治疗的临床效果：II期单臂多中心研究的结果
8. Impact of prior anthracycline or taxane use on eribulin effectiveness as first-line treatment for metastatic breast cancer: results from two phase 2, multicenter, single-arm studies [O] . 2015

机译：先前使用蒽环类或紫杉烷类药物作为转移性乳腺癌一线治疗药物对eribulin的影响：2期，多中心，单组研究的结果

Phase II, Multicenter, Single-Arm, Feasibility Study of Eribulin Combined With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive, Early-Stage Breast Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅